Iris Bincovich appears in 5 stories and 2 CSE TV videos from the Canadian Securities Exchange since 2019.
Companies in these stories: ATL (CSE:ATL), InnoCan Pharma Corporation (CSE:INNO)
This week we take the show on-the-road to Tel Aviv, Israel where we get caught up with tech executives in the health tech, cannabis, life sciences and food tech sectors. First-up is an intro to VVT Medical led by Erez Tetro and Concenter BioPharma, led by Dror Chevion. After introducing their respective businesses Erez and…
(CSE:ATL)
CSE’s Barrington Miller is joined by Iris Bincovich, CEO of InnoCan Pharma (CSE:INNO) to discuss the company’s focus as a specialty pharmaceutical company including the development of products that harness the unique properties of Cannabinoids combined with smart delivery formulations. The conversation also highlights the importance – and impact – that achieving milestones has had…
InnoCan Pharma Corporation (CSE:INNO)
CBD is advertised as providing relief for anxiety, depression and post-traumatic stress disorder, among other benefits. Its popularity reflects, in part, that it is positioned as non-psychoactive while still providing access to many aspects of the cannabis plant that are good for human health. The challenge is to create a more precise and efficient method…
CSE’s Barrington Miller recently chatted with Iris Bincovich, the CEO of InnoCan Pharma Corporation (CSE:INNO) to discuss their recent patent application. In this chat, Iris shares how her team is designing CBD-loaded exosomes for targeting Coronavirus infected lung cells (2:15), how to improve CBD delivery through an injectable solution (7:53), and her prospects concerning a…
The CSE was happy to join InnoCan Pharma Corporation (CSE:INNO) for a Market Open from a special international location, with members of the InnoCan team ringing the bell on a beach in Tel Aviv, Israel. InnoCan Pharma Corporation is an Israel-based speciality pharmaceutical company that uses cannabis products to target health issues. The company specializes…
